Steffen Lang, president, operations, executive committee member, Novartis, discusses what to expect from Novartis over the next decade in terms of technological innovations.

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Chris O’Dell, Turquoise Health’s SVP of market solutions, discusses the biggest challenges healthcare ...

Once a specialty prescription is written, fulfillment can become derailed at any number of points in the process. It can be ...

Why taking proactive steps—and combing the right data sources—is critical to informed decision-making in risk management.

In the third part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy ...

How data-driven insights can help pharma companies balance their revenue management and innovation strategies—including ...

Healthcare costs, insurance barriers, and medical debt are preventing patients with chronic illnesses in the US from ...

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief medical officer, uncovers the main reasons why 52% of respondents choose DTC ...

Respective industry and government agendas could significantly reshape the US prescription drug market.

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief ...

A panel discussion breaks down ways for stakeholders to meet temperature-controlled operational demands pertaining to product ...